Stage III–IVA MMRd/p53 wt endometrioid carcinoma with no residual diseaseStage I–IVA p53abn endometrial carcinoma with myometrial invasion, with no residual diseaseStage I–IVA p53 wt/MMRd serous, undifferentiated carcinoma, carcinosarcoma with myometrial invasion, with no residual disease. This evidence concerns the gene TP53 and undifferentiated carcinoma.